Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
14:55
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

50th ERA-EDTA Congress

 

May 18-21 2013 Istanbul
FAQs
   
Discussion forum - 50th ERA-EDTA Congress
    Topic - Clinical nephrology - IgA Nephropathy, lupus nephritis, vasculitis

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 328
Visits: 36
Title: ANTI-PHOSPHOLIPID NEPHROPATHY ONLY BELONGS TO MYAKIS I E IIA CLASSES, ALWAYS IN ASSOCIATION WITH LUPUS ANTICOAGULANT, BUT NEVER ANTI-B2GP1 ANTIBODIES
Authors: Andrea Airoldi , Cristina Izzo,1 Marco Quaglia,1 Elisabetta Radin,1 Andrea Airoldi,1 Roberta Fenoglio,1 Elisa Lazzarich,1 Piero Stratta.1
Centre: Clinical and Experimental Medicine, Nephrology and Transplantation, Amedeo Avogadro University- Maggiore Hospital

You must be registered to reply or comment.

ANTI-PHOSPHOLIPID NEPHROPATHY ONLY BELONGS TO MYAKIS I E IIA CLASSES, ALWAYS IN ASSOCIATION WITH LUPUS ANTICOAGULANT, BUT NEVER ANTI-B2GP1 ANTIBODIES

Andrea Airoldi
Thread initiator
Subspeciality
Reg: 4/27/2009 7:55:00 PM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 4/23/2013 12:36:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 15
Visits: 822
Title: EFFECTS OF UREMIC TOXIN P-CRESOL ON PROLIFERATION, APOPTOSIS, DIFFERENTIATION AND GLUCOSE UPTAKE IN 3T3-L1 CELLS
Authors: Sayuri Tanaka , Sayuri Tanaka,1 Shozo Yano,2 Toshitsugu Sugimoto.1
Centre: Shimane University Faculty of Medicine

Poster most viewed in this topic
Poster: 307
Visits: 142
Title: EFFICACY AND SAFETY OF TELMISARTAN, CLOPIDOGRELIN, AND LEFLUNOMIDE IN PATIENTS WITH IgA NEPHROPATHY A MULTICENTE, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND AND -DUMMY CONTROLLED CLINICAL TRIAL
Authors: Jie Wu , Jie Wu,1 Shuwei Duan,1 Wenge Li,1 Yaping Wang,1 Wenhu Liu,1 Jianrong Zhang,1 Lide Lun,1 Xuemei Li,1 Chunhua Zhou,1 Ying Zheng,1 Shuwen Liu,1 Yuansheng Xie,1 Guangyan Cai,1 Xiangmei Chen.1
Centre: Department of Nephrology, the Chinese PLA General Hospital


 






PosterSessionOnline
Logo Draft
 
Logo Cert